dukeeye.org

DUKE EYE CENTER

DUKE UNIVERSITY MEDICAL CENTER

enlarge textreduce text
World-Class Eye Care and ResearchGo to featured information.Accessibility Statement

Focus on Research

Focus on Research at Duke Eye Center

From Bench to Bedside: Providing Hope and Sight Tomorrow

Since the department’s beginning in 1968 and the opening of the original Wadsworth Building in 1973, the mission of the Duke Eye Center has been aimed at serving humankind. Both the building and its programs have been focused on:

  • Utilizing the latest scientific advances and technology.
  • Applying the abilities of skilled and internationally recognized scientists and physicians.
  • Providing a caring and compassionate staff.

Transgenic Pigs and Retinitis Pigmentosa

A partnership between basic science researcher, Fulton Wong, PhD, MPP, Director of Research and renowned retinal surgeon, Brooks McCuen, MD, Vice Chairman, Department of Ophthalmology, Chief of Vitreoretinal Service, offers new hope to patients with retinitis pigmentosa (RP). “I knew it would be a fantastic opportunity if we could create a pig model that was genetically engineered, because if we could simulate [RP] in the pig, then we could watch how the disease developed. Ours are the only pigs in the world to test RP therapies. If there is a treatment, we will find it,” said Wong.

“Dr. Wong approached me…the idea was for me as a clinician and a surgeon to help test various treatments for RP…the pig eye is more similar to the human than different...To be able to partner with Dr. Wong has been a wonderful experience…it really helps us to get a more unified and beneficial idea of where to go,” said McCuen.

Stem Cell Therapy and Retinal Degeneration

Neurobiologist Dennis Rickman, PhD, focuses primarily on how cells in the retina develop under normal conditions and under experimental stress. His studies provide insight into how cells might be repaired or regenerate after they are damaged or die from disease.

“Currently, there are really no therapies for successfully replacing cells that have died. We are looking at adult-derived stem cells…to eventually take stem cells from the patient’s own body…and inject them into the eye to replace the cells that are dying. The hope is, we all have our own accessible stem cells that are like our personal bag of ‘spare parts’… The challenge is…to learn how to tweak the cells into becoming what we want them to be and to create an environment in which these cells could grow and thrive,” said Rickman.

Glaucoma and the Ghana Genetic Linkage Project

Rand Allingham, MD, Chief of the Glaucoma Service and Barkhouser Scholar, spearheaded establishing a project to enroll Ghanaian families with glaucoma in Duke’s Primary Open Angle Glaucoma (POAG) Genetic Linkage Study. The incidence of identified glaucoma in the Ghanaian population is extremely high and therefore ideal for genetic analysis. This study is designed to identify the genes responsible for POAG, the most prevalent form of glaucoma. Duke is the only American medical center involved in this unique project. The National Eye Institute is funding the US arm of the study.

More Information

Focus on Research

Meet the Researchers

Postdoctoral Fellowship Program

AERI Dedication

Research News

Research Brochure